12.39
Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
3.18%
35.82
|
36.99 | 29.59 | 29.01 | 28.80 |
| Operating Income/Loss |
3.18%
-35.82
|
-36.99 | -29.59 | -29.01 | -28.80 |
| Nonoperating Income/Loss |
15.76%
2.768
|
3.286 | 3.965 | 4.48 | 4.631 |
| Income/Loss From Continuing Operations Before Tax |
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
| Income/Loss From Continuing Operations After Tax |
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
|
|
1.95%
-33.05
|
-33.71 | -25.63 | -24.53 | -24.17 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.00%
58.01
|
58.01 | 0.6192 | 57.82 | 56.49 |
| Diluted Average Shares |
0.00%
58.01
|
58.01 | 0.6192 | 57.82 | 56.49 |
| Basic Earnings Per Share |
1.72%
-0.57
|
-0.58 | -0.44 | -0.42 | -0.43 |
| Diluted Earnings Per Share |
1.72%
-0.57
|
-0.58 | -0.44 | -0.42 | -0.43 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):